Market Cap | 322.19B | P/E | 50.99 | EPS this Y | -6.20% | Ern Qtrly Grth | 30.80% |
Income | 6.03B | Forward P/E | 28.93 | EPS next Y | 8.20% | 50D Avg Chg | -6.00% |
Sales | 29.24B | PEG | 2.50 | EPS past 5Y | 13.03% | 200D Avg Chg | 3.00% |
Dividend | 1.00% | Price/Book | 30.31 | EPS next 5Y | 17.90% | 52W High Chg | -12.00% |
Recommedations | 2.00 | Quick Ratio | 0.70 | Shares Outstanding | 0.95B | 52W Low Chg | 46.00% |
Insider Own | 0.15% | ROA | 11.48% | Shares Float | 0.95B | Beta | 0.38 |
Inst Own | 84.89% | ROE | 66.59% | Shares Shorted/Prior | 4.93M/5.62M | Price | 339.08 |
Gross Margin | 75.28% | Profit Margin | 20.63% | Avg. Volume | 2,886,729 | Target Price | 388.95 |
Oper. Margin | 30.05% | Earnings Date | Apr 27 | Volume | 5,069,937 | Change | 2.53% |
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Barclays | Overweight | Jan 3, 23 |
SVB Leerink | Outperform | Dec 16, 22 |
UBS | Buy | Dec 15, 22 |
Morgan Stanley | Overweight | Dec 14, 22 |
Wells Fargo | Equal-Weight | Dec 8, 22 |
Guggenheim | Buy | Dec 7, 22 |
Morgan Stanley | Overweight | Dec 6, 22 |
Credit Suisse | Outperform | Dec 6, 22 |
Cowen & Co. | Outperform | Dec 5, 22 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Dec 02 | Sell | 372.97 | 49,089 | 18,308,724 | 102,948,810 | 12/05/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Dec 01 | Sell | 373.31 | 160,911 | 60,069,685 | 102,997,899 | 12/02/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Nov 07 | Sell | 364.42 | 63,585 | 23,171,646 | 103,158,810 | 11/08/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Nov 02 | Sell | 362.07 | 6,131 | 2,219,851 | 103,357,679 | 11/03/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Oct 18 | Sell | 334.29 | 12,042 | 4,025,520 | 103,529,293 | 10/19/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Oct 14 | Sell | 334.42 | 3,187 | 1,065,797 | 103,620,959 | 10/17/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Oct 06 | Sell | 336.56 | 149,264 | 50,236,292 | 103,624,546 | 10/07/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Sep 28 | Sell | 336.99 | 101,631 | 34,248,631 | 103,773,810 | 09/29/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Jul 28 | Sell | 333.18 | 89,458 | 29,805,616 | 103,875,441 | 07/29/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Jul 26 | Sell | 332.524 | 1,601 | 532,371 | 103,964,899 | 07/27/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Jul 15 | Sell | 334 | 17,310 | 5,781,540 | 103,966,500 | 07/18/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Jul 06 | Sell | 330.88 | 177,243 | 58,646,164 | 103,983,810 | 07/07/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Jun 28 | Sell | 329.01 | 900 | 296,109 | 104,161,053 | 06/29/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Jun 27 | Sell | 329.045 | 41,857 | 13,772,837 | 104,161,953 | 06/28/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Jun 24 | Sell | 323.95 | 215,000 | 69,649,250 | 104,203,810 | 06/27/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Jun 23 | Sell | 311.37 | 205,000 | 63,830,850 | 104,418,810 | 06/24/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Jun 22 | Sell | 307.35 | 210,000 | 64,543,500 | 104,623,810 | 06/23/22 |
Zakrowski Donald A | Chief Accounting Off.. Chief Accounting Officer | Jun 01 | Sell | 313.44 | 1,000 | 313,440 | 6,274 | 06/02/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | May 25 | Sell | 309.36 | 41,610 | 12,872,470 | 105,212,200 | 05/26/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | May 24 | Sell | 306.01 | 100,000 | 30,601,000 | 105,253,810 | 05/25/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | May 23 | Sell | 303.37 | 118,856 | 36,057,345 | 105,353,810 | 05/24/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | May 18 | Sell | 302.00 | 700 | 211,400 | 105,472,666 | 05/19/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | May 17 | Sell | 302.73 | 19,683 | 5,958,635 | 105,473,366 | 05/18/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | May 16 | Sell | 302.75 | 80,761 | 24,450,393 | 105,493,049 | 05/17/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Apr 08 | Sell | 310.88 | 139,045 | 43,226,310 | 105,573,810 | 04/11/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Apr 06 | Sell | 301.11 | 51,851 | 15,612,855 | 105,783,810 | 04/07/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Apr 05 | Sell | 294.4 | 113,756 | 33,489,766 | 105,835,661 | 04/06/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Apr 04 | Sell | 293.152 | 39,393 | 11,548,137 | 105,949,417 | 04/05/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Mar 30 | Sell | 292.03 | 2,500 | 730,075 | 106,154,186 | 03/31/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Mar 28 | Sell | 292.155 | 7,538 | 2,202,264 | 106,161,027 | 03/29/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Mar 18 | Sell | 288.4 | 210,000 | 60,564,000 | 106,203,810 | 03/21/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Mar 17 | Sell | 283.95 | 220,000 | 62,469,000 | 106,413,810 | 03/18/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Mar 15 | Sell | 273.77 | 220,075 | 60,249,933 | 106,633,810 | 03/16/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Mar 14 | Sell | 269.73 | 173,085 | 46,686,217 | 106,853,885 | 03/15/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Mar 11 | Sell | 269.047 | 21,840 | 5,875,986 | 107,026,970 | 03/14/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Mar 10 | Sell | 266.8 | 184,982 | 49,353,198 | 107,048,810 | 03/11/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Mar 09 | Sell | 266.94 | 20,018 | 5,343,605 | 107,233,792 | 03/10/22 |
Runge Marschall S | Director Director | Mar 01 | Buy | 246.78 | 202 | 49,850 | 15,436 | 03/07/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Mar 04 | Sell | 262.14 | 210,000 | 55,049,400 | 107,253,810 | 03/07/22 |
Jonsson Patrik | SVP&Pres, LLY Imm, L.. SVP&Pres, LLY Imm, LLY USA&CCO | Mar 01 | Sell | 247.56 | 675 | 167,103 | 32,035 | 03/03/22 |
Zakrowski Donald A | Chief Accounting Off.. Chief Accounting Officer | Feb 25 | Sell | 243.84 | 1,660 | 404,774 | 7,274 | 02/28/22 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Jun 10 | Sell | 225.21 | 220,000 | 49,546,200 | 109,652,100 | 06/10/21 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | May 24 | Sell | 200.78 | 92,740 | 18,620,337 | 110,109,429 | 05/24/21 |
TAI JACKSON P | Director Director | May 03 | Buy | 182.87 | 1,366 | 249,800 | 61,195 | 05/03/21 |
LILLY ENDOWMENT INC | 10% Owner 10% Owner | Jan 12 | Sell | 186.24 | 220,000 | 40,972,800 | 110,912,343 | 01/12/21 |